arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Coya Therapeutics, Inc.

COYA Health Care Biotechnology: Pharmaceutical Preparations
$3.94
▼ -4.8% Today
as of Oct 23, 16:47 ET
Last 30 days -15.09% Sep 14 → Oct 23
$3.83 $4.23 $4.62 $5.01 $5.41 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$4.08
High
$4.25
Low
$3.94
Volume
$187,425
Avg Vol
$184,896
Mkt Cap
$111M
P/E (TTM)
—
Beta
—
52w High
$6.81
52w Low
$3.71
Div Yield
—
Shares Out
$23M

Recent Press Releases & News last 60 days · 5 items

Oct 14 · 12:00 PR Business Wire
Coya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS
Oct 13 · 12:00 PR Business Wire
Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
Oct 5 · 12:00 PR Business Wire
Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
▸ Show all 5 press releases & news Free account →

COYA earnings at a glance

The options market is pricing a move of about ±10.0% after the report, a range of roughly $3.55 to $4.33 from today's $3.94. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.4% on average; after the most recent report on May 12, 2026 it moved +2.6%. That means options currently expect more movement than COYA has typically delivered. COYA beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 85%. The share price of $3.94 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.71
$6.81
7% of range
Avg surprise (last 4)
-161.4%
Avg reaction (last 2)
-1.8%
50% positive
Latest IV / EM
85%
EM ±10.0% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.44$-0.33$-0.21$-0.09$0.02 Actual $-0.28Actual $-0.31Actual $-0.34Actual $-0.35Actual $-0.19Actual $-0.26Actual $-0.44Est $-0.44Actual $-0.36Est $-0.22Actual $-0.10Est $0.02Actual $-0.32Est $-0.39Actual $-0.28 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-7M$-5M$-2M$980,161$4M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.28 — — — — financials
Tue May 12, 2026Mar/2026 $-0.32 $-0.39 +17.9% +27.3% +2.6% earnings
Wed Nov 12, 2025Sep/2025 $-0.10 $0.02 -600.0% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.36 $-0.22 -63.6% — — earnings
Tue May 13, 2025Mar/2025 $-0.44 $-0.44 0.0% — -6.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.26 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.19 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.35 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.34 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.31 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.28 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$243,745$251,147—$4M$163,616$257,884—$0
Cost of revenue————————
Gross profit————————
Operating income$-7M$-8M—$-2M$-6M$-8M—$-4M
Net income$-7M$-7M—$-2M$-6M$-7M—$-4M
EPS (diluted)$-0.28$-0.32—$-0.13$-0.36$-0.44—$-0.26

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$43M$51M$47M$28M$30M$36M$38M$31M
Inventory————————
Total current assets$47M$53M$50M$32M$33M$38M$44M$36M
Total assets$47M$53M$50M$32M$33M$38M$44M$36M
Long-term debt————————
Total liabilities$4M$4M$7M$5M$5M$5M$5M$4M
Total equity$43M$49M$43M$27M$28M$33M$40M$32M

Implied volatility — last 90 days

53%649%1246%1843%2439% Jun 10 — IV 960% · EM ±113.4%Jun 11 — IV 1012% · EM ±111.9%Jun 29 — IV 191% · EM ±33.8%Jun 30 — IV 526% · EM ±90.6%Jul 08 — IV 267% · EM ±33.4%Jul 13 — IV 111% · EM ±9.3%Jul 14 — IV 128% · EM ±9.3%Jul 16 — IV 1744% · EM ±72.8%Jul 22 — IV 145% · EM ±33.2%Jul 28 — IV 348% · EM ±71.2%Aug 24 — IV 468% · EM ±97.8%Aug 25 — IV 53% · EM ±10.9%Sep 09 — IV 156% · EM ±19.5%Sep 10 — IV 253% · EM ±29.9%Sep 11 — IV 1043% · EM ±115.3%Sep 14 — IV 1251% · EM ±104.5%Sep 15 — IV 373% · EM ±26.9%Sep 16 — IV 1841% · EM ±108.7%Sep 17 — IV 2440% · EM ±101.9%Sep 22 — IV 143% · EM ±29.2%Sep 23 — IV 119% · EM ±23.8%Sep 24 — IV 125% · EM ±24.4%Sep 25 — IV 139% · EM ±26.6%Sep 30 — IV 60% · EM ±10.0%Oct 01 — IV 157% · EM ±25.4%Oct 02 — IV 153% · EM ±23.9%Oct 06 — IV 86% · EM ±11.3%Oct 07 — IV 81% · EM ±10.2%Oct 08 — IV 85% · EM ±10.0%

Sector peers

PYPD
PolyPid Ltd.
$109M $5.25+3.5%
GNLX
Genelux Corporation
$114M $2.00-3.4%
LIXT
Lixte Biotechnology Holdings, Inc.
$115M $7.21+75.8%
AARD
Aardvark Therapeutics, Inc.
$115M $1.39-68.5%
ZSTK
ZeroStack Corp.
$104M $3.28-8.1%
MIST
Milestone Pharmaceuticals Inc.
$102M $0.65-6.7%

COYA earnings FAQ

What is COYA's expected move for earnings?

Options currently price a move of about ±10.0%, or $0.39 per share either way from $3.94.

How does COYA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.4%, up 1 times and down 1 times.

What is COYA's implied volatility?

COYA's at-the-money implied volatility is about 85% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in